{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:50:34Z","timestamp":1790239834413,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.dld.2007.03.009","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T08:54:55Z","timestamp":1180083295000},"page":"634-641","source":"Crossref","is-referenced-by-count":72,"title":["Disappointing outcome of autologous stem cell transplantation for enteropathy-associated T-cell lymphoma"],"prefix":"10.1016","volume":"39","author":[{"given":"A.","family":"Al-toma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.H.M.","family":"Verbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.J.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.C.","family":"Kuijpers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"Oudejans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.C.","family":"Kluin-Nelemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.J.J.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.C.","family":"Huijgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2007.03.009_bib1","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1200\/JCO.2000.18.4.795","article-title":"Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center","volume":"18","author":"Gale","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.dld.2007.03.009_bib2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00004836-199509000-00012","article-title":"Celiac-associated lymphoma. A single institution experience of 30 cases in the combination chemotherapy era","volume":"21","author":"Egan","year":"1995","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2007.03.009_bib3","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1200\/JCO.2003.06.026","article-title":"Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma","volume":"21","author":"Daum","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.dld.2007.03.009_bib4","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/jama.287.11.1413","article-title":"Non Hodgkin's lymphoma: risk of non-Hodgkin lymphoma in celiac disease","volume":"287","author":"Catassi","year":"2002","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.dld.2007.03.009_bib5","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1053\/j.gastro.2005.02.027","article-title":"Association of celiac disease and intestinal lymphomas and other cancers","volume":"128","author":"Catassi","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2007.03.009_bib6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/gut.30.3.333","article-title":"Malignancy in coeliac disease\u2014effect of a gluten free diet","volume":"30","author":"Holmes","year":"1989","journal-title":"Gut"},{"key":"10.1016\/j.dld.2007.03.009_bib7","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s00277-004-0953-9","article-title":"Enteropathy-associated T-cell lymphoma without a prior diagnosis of coeliac disease: diagnostic dilemmas and management options","volume":"84","author":"Honemann","year":"2005","journal-title":"Ann Hematol"},{"key":"10.1016\/j.dld.2007.03.009_bib8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(00)02481-8","article-title":"Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma, French Coeliac Disease Study Group","volume":"356","author":"Cellier","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2007.03.009_bib9","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/gut.49.6.804","article-title":"Intestinal Lymphoma Study G: frequency of clonal intraepithelial T lymphocyte proliferations in enteropathy-type intestinal T cell lymphoma, coeliac disease, and refractory sprue","volume":"49","author":"Daum","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.dld.2007.03.009_bib10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000007779","article-title":"Refractory sprue syndrome with clonal intraepithelial lymphocytes evolving into overt enteropathy type intestinal T-cell lymphoma","volume":"62","author":"Daum","year":"2000","journal-title":"Digestion"},{"key":"10.1016\/j.dld.2007.03.009_bib11","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0016-5085(98)70530-X","article-title":"Abnormal intestinal intraepithelial lymphocytes in refractory sprue","volume":"114","author":"Cellier","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2007.03.009_bib12","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1182\/blood.V92.10.3879","article-title":"Are complicated forms of celiac disease cryptic T-cell lymphomas?","volume":"92","author":"Carbonnel","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.dld.2007.03.009_bib13","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1309\/EVXT-851X-WHLC-RLX9","article-title":"Histologic follow-up of people with celiac disease on a gluten-free diet: slow and incomplete recovery","volume":"118","author":"Wahab","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.dld.2007.03.009_bib14","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2169\/internalmedicine.41.734","article-title":"CD56 positive intestinal T-cell lymphoma: treatment with high dose chemotherapy and autologous peripheral blood stem cell transplantation","volume":"41","author":"Okuda","year":"2002","journal-title":"Intern Med"},{"key":"10.1016\/j.dld.2007.03.009_bib15","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/s10620-006-8013-z","article-title":"Successful treatment of enteropathy-associated T cell lymphoma with autologous stem cell transplant","volume":"51","author":"Rongey","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2007.03.009_bib16","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1080\/1042819031000123456","article-title":"High-dose therapy supported by autologous stem cell transplantation in patients with enteropathy-associated T-cell lymphoma","volume":"44","author":"Jantunen","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.dld.2007.03.009_bib17","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/sj.bmt.1702867","article-title":"High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas","volume":"27","author":"Blystad","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.dld.2007.03.009_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2141.2006.06371.x","article-title":"Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T cell lymphoma","volume":"136","author":"Bishton","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.dld.2007.03.009_bib19","first-page":"1622","article-title":"18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease","volume":"47","author":"Hadithi","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.dld.2007.03.009_bib20","series-title":"Classification of tumours: pathology and genetics of tumours of hematopoietic and lymphoid tissues","first-page":"208","article-title":"Enteropathy-type T-cell lymphoma","author":"Isaacson","year":"2001"},{"key":"10.1016\/j.dld.2007.03.009_bib21","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.dld.2007.03.009_bib22","first-page":"191","article-title":"A single-center report on clinical features and treatment response in patients with intestinal T cell non-Hodgkin's lymphomas","volume":"16","author":"Novakonic","year":"2006","journal-title":"Oncol Rep"},{"key":"10.1016\/j.dld.2007.03.009_bib23","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1365-2141.2002.03636.x","article-title":"Granulocyte colony-stimulating factor mobilized whole blood containing over 0.3\u00d7106\/kg CD34+ cells is a sufficient graft in autologous transplantation for relapsed non-Hodgkin's lymphoma","volume":"118","author":"Jonkhoff","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.dld.2007.03.009_bib24","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1182\/blood-2006-08-042820","article-title":"Autologous haematopoietic stem cell transplantation in refractory coeliac disease with aberrant T-cells","volume":"109","author":"Al-toma","year":"2007","journal-title":"Blood"},{"issue":"2 Suppl 5","key":"10.1016\/j.dld.2007.03.009_bib25","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1053\/j.seminoncol.2006.01.029","article-title":"The role of alemtuzumab in the management of T-cell malignancies","volume":"33","author":"Dearden","year":"2006","journal-title":"Semin Oncol"},{"key":"10.1016\/j.dld.2007.03.009_bib26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00277-002-0450-y","article-title":"A single-centre study of treatment outcomes and survival in 120 patients with peripheral T-cell non-Hodgkin's lymphoma","volume":"81","author":"Pellatt","year":"2002","journal-title":"Ann Hematol"},{"key":"10.1016\/j.dld.2007.03.009_bib27","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood.V104.11.2640.2640","article-title":"Combination chemoimmunotherapy using alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin is an effective first-line regimen in peripheral T-cell lymphomas","volume":"104","author":"Weidmann","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.dld.2007.03.009_bib28","first-page":"321","article-title":"CHOP chemotherapy plus Campath-1H (CHOP-C) as first line treatment in patients with peripheral T-cell lymphoma (PTCL)","volume":"16","author":"Gallamini","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.dld.2007.03.009_bib29","first-page":"2384","article-title":"A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphoma","volume":"102","author":"Enblad","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.dld.2007.03.009_bib30","first-page":"6453","article-title":"Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD52 monoclonal antibody, Campath-1H","volume":"63","author":"Zhang","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.dld.2007.03.009_bib31","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1200\/JCO.1997.15.2.491","article-title":"Intensified and high-dose chemotherapy with granulocyte colony-stimulating factor and autologous stem-cell transplantation support as first-line therapy in high-risk diffuse large-cell lymphoma","volume":"15","author":"Vitolo","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.dld.2007.03.009_bib32","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/annonc\/mdg200","article-title":"Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin's lymphoma","volume":"14","author":"Hosing","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.dld.2007.03.009_bib33","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2141.2005.05755.x","article-title":"Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphoma","volume":"131","author":"Doocey","year":"2005","journal-title":"Br J Haematol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865807001302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865807001302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T07:15:53Z","timestamp":1587539753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865807001302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S1590865807001302"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2007.03.009","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.722899730.793523663","asserted-by":"object"}]},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}